535217 — HPC Biosciences Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual income statement for HPC Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	PRESS	PRESS
Standards:	IAS	IAS	IAS	—	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	16	12	22.9	4.9	2.11
Cost of Revenue
Gross Profit	15.6	11.2	20.3	-0.583	2.11
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	11.1	9.43	11.8	13.9	7.35
Operating Profit	4.88	2.57	11.1	-8.98	-5.24
Other Net Non Operating Costs
Net Income Before Taxes	5.77	3.59	11.9	-4.81	0.286
Provision for Income Taxes
Net Income After Taxes	5.54	3.37	11.7	-4.94	0.212
Net Income Before Extraordinary Items
Net Income	5.54	3.37	11.7	-4.94	0.212
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5.54	3.37	11.7	-4.94	0.211
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.035	0.021	0.073	-0.031	0.001